- Home
- GLP vs NVCR Comparison
GLP vs NVCR Comparison
Compare GLP & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLP
- NVCR
- Stock Information
- Founded
- GLP 2005
- NVCR 2000
- Country
- GLP United States
- NVCR Switzerland
- Employees
- GLP N/A
- NVCR N/A
- Industry
- GLP Oil Refining/Marketing
- NVCR Medical/Dental Instruments
- Sector
- GLP Energy
- NVCR Health Care
- Exchange
- GLP Nasdaq
- NVCR Nasdaq
- Market Cap
- GLP 1.7B
- NVCR 1.4B
- IPO Year
- GLP 2005
- NVCR 2015
- Fundamental
- Price
- GLP $45.43
- NVCR $14.23
- Analyst Decision
- GLP Hold
- NVCR Buy
- Analyst Count
- GLP 1
- NVCR 7
- Target Price
- GLP $56.00
- NVCR $28.79
- AVG Volume (30 Days)
- GLP 77.2K
- NVCR 1.9M
- Earning Date
- GLP 11-07-2025
- NVCR 10-30-2025
- Dividend Yield
- GLP 6.50%
- NVCR N/A
- EPS Growth
- GLP N/A
- NVCR N/A
- EPS
- GLP 2.60
- NVCR N/A
- Revenue
- GLP $17,827,598,000.00
- NVCR $630,160,000.00
- Revenue This Year
- GLP $37.98
- NVCR $6.68
- Revenue Next Year
- GLP $28.27
- NVCR $7.01
- P/E Ratio
- GLP $17.76
- NVCR N/A
- Revenue Growth
- GLP 3.74
- NVCR 14.58
- 52 Week Low
- GLP $43.20
- NVCR $10.87
- 52 Week High
- GLP $60.00
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- GLP 31.98
- NVCR 62.07
- Support Level
- GLP $45.68
- NVCR $13.94
- Resistance Level
- GLP $50.95
- NVCR $14.77
- Average True Range (ATR)
- GLP 1.08
- NVCR 0.53
- MACD
- GLP -0.35
- NVCR 0.16
- Stochastic Oscillator
- GLP 18.23
- NVCR 74.38
About GLP Global Partners LP Common Units representing Limited Partner Interests
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.